Search Results - Otero‐Lobato, Marijo

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006–2019

    Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006–2019 by Karlsson, Pär, Gembert, Karin, Esslinger, Suzan, Geldhof, Anja, Gissler, Mika, Leinonen, Maarit K., Otero‐Lobato, Marijo, Pedersen, Lars, Cesta, Carolyn E.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Exposure to golimumab during pregnancy: Results from the Company's global safety database

    Exposure to golimumab during pregnancy: Results from the Company's global safety database by Otero‐Lobato, Marijo, Adeyemo, Adesoji, Higley, Michelle, Lomax, Kathleen G., Geldhof, Anja, Esslinger, Suzan

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Risk Management Plans: reassessment of safety concerns based on Good Pharmacovigilance Practices Module V (Revision 2)-a company experience

    Risk Management Plans: reassessment of safety concerns based on Good Pharmacovigilance Practices Module V (Revision 2)-a company experience by Esslinger, Suzan, Quinn, Linda, Sampat, Sami, Otero-Lobato, Marijo, Noël, Wim, Geldhof, Anja, Herijgers, Nicole, Reeder, Sarah-Jane

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Effectiveness of the golimumab educational program in ensuring healthcare professionals' awareness of risks described in the European risk management plan

    Effectiveness of the golimumab educational program in ensuring healthcare professionals' awareness of risks described in the European risk management plan by Felo, Lauren, Otero-Lobato, Marijo, Geldhof, Anja, Noël, Wim

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Post-approval Safety Surveillance Study of Golimumab in the Treatment of Rheumatic Disease Using a United States Healthcare Claims Database

    Post-approval Safety Surveillance Study of Golimumab in the Treatment of Rheumatic Disease Using a United States Healthcare Claims Database by Ziyadeh, Najat J., Geldhof, Anja, Noël, Wim, Otero-Lobato, Marijo, Esslinger, Suzan, Chakravarty, Soumya D., Wang, Yiting, Seeger, John D.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: